Linda Lai

Linda Lai, PhD, is currently working as a Senior Clinical Trial Manager at Tizona Therapeutics, Inc. Prior to this role, Linda held various positions in clinical research and administration at companies such as Loxo Oncology at Lilly, Zymeworks Inc., Cascadian Therapeutics, Inc., and the Pacific Northwest Diabetes Research Institute. Linda also has a strong educational background with a Ph.D. in Physical Chemistry from the University of Southampton, a Master's Degree in Physics & Astronomy from the University of Birmingham, and a B.Sc.(Hons) in Chemistry with Medicinal Chemistry from the University of Warwick.